NEW YORK (TheStreet) -- Shares of Novogen  (NVGN) fell 16.79% to $7.68 in late morning trading Monday after the Australian and U.S. biotechnology company announced it had conducted a private placement and offered rights to shareholders.

The company announced late Monday that it agreed to issue approximately 51 million fully-paid ordinary shares plus one attaching 6-month option and half of one attaching 5-year option for every ordinary share issued to institutional investors in the U.S. in a private placement.

The company expects aggregate gross proceeds of approximately AU$15.5 million from the placement, which is expects to close on or about April 24. 

Novogen will also undertake a 1-for-6 non-renounceable rights issue offering of fully-paid ordinary shares to raise up to a maximum of approximately AU$15 million.

More than 2 million shares had changed hands as of 11:50 a.m., compared to the daily average volume of 1,133,600.

NVGN ChartNVGN data by YCharts

More from Markets

Big Blue Looks Stronger in the Weeks Ahead - Go Long Here and on Strength

Big Blue Looks Stronger in the Weeks Ahead - Go Long Here and on Strength

What the Government Shutdown Means for Retail

What the Government Shutdown Means for Retail

Jim Cramer Explains Why Analysts Got Goldman All Wrong

Jim Cramer Explains Why Analysts Got Goldman All Wrong

BlackRock's Profit Plunges 60% as Assets Slip Below $6 Trillion

BlackRock's Profit Plunges 60% as Assets Slip Below $6 Trillion

Real Goods Solar Plows Ahead With Energy Plans

Real Goods Solar Plows Ahead With Energy Plans